Pulmatrix, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2020 Annual Meeting of Stockholders held by Pulmatrix, Inc. on June 17, 2020. The Company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market LLC under the symbol "PULM".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 17,515,283 shares were present in person or by proxy. The following matters were approved:
- Election of Directors: Michael J. Higgins and Mark Iwicki were elected as Class III directors to serve until the 2023 Annual Meeting.
- Ratification of Auditors: Marcum LLP was ratified as the independent registered public accounting firm for the 2020 fiscal year.
- Executive Compensation (Say-on-Pay): Stockholders approved, on an advisory basis, the compensation paid to named executive officers.
- Frequency of Say-on-Pay Votes: Stockholders approved holding advisory votes on executive compensation every three years.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. For further details on the proposals, the Company refers investors to its definitive proxy statement filed on April 29, 2020.
Key Facts for Investor Verification
- Verify the final voting percentages for the election of directors Michael J. Higgins and Mark Iwicki.
- Confirm the appointment of Marcum LLP as the independent auditor for the 2020 fiscal year.
- Note that the advisory vote on executive compensation frequency was set to occur every three years.
- Review the definitive proxy statement filed on April 29, 2020, for detailed background on the proposals.